Litcius/Paper detail

Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study

Eric J. Haas, John M. McLaughlin, Farid Khan, Frederick J. Angulo, Emilia Anis, Marc Lipsitch, Shepherd Roee Singer, Gabriel Mircus, Nati Brooks, Meir Smaja, Kaijie Pan, Jo Southern, David L. Swerdlow, Luis Jódar, Yeheskel Levy, Sharon Alroy‐Preis

2021The Lancet Infectious Diseases135 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVaccinationChristian ministryPediatricsCoronavirus disease 2019 (COVID-19)Retrospective cohort studySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PopulationVirologyInternal medicineEnvironmental healthDiseaseInfectious disease (medical specialty)TheologyPhilosophySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyImmune responses and vaccinations
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study | Litcius